One of the most difficult experiences a person can face is being told that they may only have months—or perhaps a few years—left to live. In such moments, treatments once intended to cure the disease may no longer be effective, and even advances in medicine and technology cannot always change the outcome.

For many people living with a terminal illness, the disease does more than threaten their life. It can dramatically reshape their expectations for the future. Plans, milestones, and time once imagined with loved ones may suddenly feel uncertain or out of reach.

In these circumstances, the goal of care often shifts. Rather than focusing solely on curing the disease, healthcare providers and patients may prioritize reducing suffering and improving quality of life.

This is where palliative care plays an essential role. In recent years, medical cannabis has become an increasingly discussed option in conversations about symptom management and comfort during the final stages of life.


Medical Cannabis and Palliative Care

In some countries and regions, medical cannabis is legally permitted for certain medical uses. Research suggests that cannabis and its related compounds may help relieve symptoms such as pain, nausea, anxiety, and loss of appetite—issues that are commonly experienced by patients receiving palliative or hospice care.

For example, a survey conducted by the U.S.-based organization Enclara Pharmacia, in collaboration with the National Hospice and Palliative Care Organization, gathered responses from more than 500 hospice programs. Approximately 310 clinicians—primarily nurses—from 40 states participated in the anonymous online survey.

Many respondents reported that medical cannabis appeared to be helpful in managing symptoms such as anxiety, nausea, pain, and vomiting. However, the study also revealed an interesting gap: although many healthcare providers expressed support for its use, physicians were less likely to initiate conversations about medical cannabis with patients. Researchers suggested that this hesitation may be related to limited training or education on the topic.

Some studies have also explored potential associations between cannabis-based treatments and survival time. In one study conducted by German researchers, investigators examined data from patients registered in a specialized outpatient palliative care program (SAPV). The analysis found that treatment with cannabinoid-based medications was associated with a longer median survival time, increasing from approximately 44 days to 65 days. The association appeared to be more pronounced among female patients over the age of 75.

However, researchers emphasized that these findings are observational and require further study to better understand the potential relationship between cannabis-based therapies and patient outcomes.

Overall, existing research suggests that cannabis-based treatments may have potential value for some patients receiving palliative care, although more clinical research is still needed.


Barriers to Medical Cannabis in End-of-Life Care

Despite growing interest and research, the use of medical cannabis in hospice and palliative care continues to face several challenges.

One of the most frequently discussed issues involves ethical concerns. Some critics worry that cannabis use in terminally ill patients could impair cognitive function or cause excessive sedation. Others mistakenly conflate symptom relief with giving up on treatment or even with assisted dying.

In reality, the primary purpose of palliative care interventions is to reduce discomfort and improve quality of life—not to hasten death.

Another source of debate centers on decision-making. Questions remain about who should ultimately decide whether medical cannabis is appropriate: the patient, family members, healthcare providers, or regulatory authorities. Supporters argue that patients should have access to a wider range of options when legal and medically supervised, while critics remain concerned about oversight and potential misuse.


A Lack of Medical Education

Beyond legal and ethical concerns, one often overlooked barrier is the limited education surrounding medical cannabis in healthcare training.

Even in regions where medical cannabis is legal, healthcare providers may feel uncertain about recommending or discussing its use. Many clinicians receive little formal education on topics such as cannabinoid pharmacology, potential drug interactions, dosing methods, or harm-reduction strategies.

Because these topics are not traditionally included in standard medical curricula, some physicians may feel unprepared to answer patient questions or to incorporate cannabis into a palliative care plan.

Hospice and palliative care institutions also face operational challenges. These organizations must follow strict regulatory standards to minimize liability. In many cases, medical cannabis does not yet fit neatly within existing hospice care models, and staff may lack clear guidelines on how to store, manage, or document its use.


Conclusion

As research continues to expand, the potential role of medical cannabis in palliative care is receiving increasing attention. For some patients facing the end of life, relief from pain, improved sleep, restored appetite, or reduced anxiety can significantly affect their comfort and well-being.

Discussions around medical cannabis are likely to continue evolving as legal frameworks, medical knowledge, and patient needs develop. Within a regulated and medically supervised context, exploring additional options for symptom management may help support a more compassionate and patient-centered approach to end-of-life care.


Disclaimer

This article is intended for informational purposes only and does not constitute medical advice. Patients should consult qualified healthcare professionals before making decisions about medical treatments or medications.